Evidence map›Paper›PMID 38062750›Full record

ArticleACS applied bio materials2023

Fine-Tuning the Nanostructured Titanium Oxide Surface for Selective Biological Response.

Niharika Rawat, Metka Benčina, Domen Paul, Janez Kovač, Katja Lakota, Polona Žigon, Veronika Kralj-Iglič, Hsin-Chia Ho, Marija Vukomanović, Aleš Iglič and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied bio materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Niharika RawatLaboratory of Physics, Faculty of Electrical Engineering, University of Ljubljana, Tržaška 25, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-7883-1590
Metka BenčinaLaboratory of Physics, Faculty of Electrical Engineering, University of Ljubljana, Tržaška 25, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-6431-6544
Domen PaulDepartment of Surface Engineering, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.
Janez KovačDepartment of Surface Engineering, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-4324-246X
Katja LakotaDepartment of Rheumatology, University Medical Centre Ljubljana, Vodnikova 62, SI-1000 Ljubljana, Slovenia.
Polona ŽigonDepartment of Rheumatology, University Medical Centre Ljubljana, Vodnikova 62, SI-1000 Ljubljana, Slovenia.
Veronika Kralj-IgličLaboratory of Clinical Biophysics, Faculty of Health Sciences, University of Ljubljana, Zdravstvena pot 5, SI-1000 Ljubljana, Slovenia.
Hsin-Chia HoAdvanced Materials Department, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-6373-9740
Marija VukomanovićAdvanced Materials Department, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.
Aleš IgličLaboratory of Physics, Faculty of Electrical Engineering, University of Ljubljana, Tržaška 25, SI-1000 Ljubljana, Slovenia.
Ita JunkarDepartment of Surface Engineering, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-1145-9883
Jožef Stefan Institute · SIUniversity of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are a pre-eminent global cause of mortality in the modern world. Typically, surgical intervention with implantable medical devices such as cardiovascular stents is deployed to reinstate unobstructed blood flow. Unfortunately, existing stent materials frequently induce restenosis and thrombosis, necessitating the development of superior biomaterials. These biomaterials should inhibit platelet adhesion (mitigating stent-induced thrombosis) and smooth muscle cell proliferation (minimizing restenosis) while enhancing endothelial cell proliferation at the same time. To optimize the surface properties of Ti

Indexed as

Biocompatible MaterialsThrombosisCell AdhesionHumansSurface PropertiesTitaniumBiocompatible MaterialsTitaniumtitanium dioxidebiocompatibilitygaseous plasma treatmenthydrothermal treatmentnanostructured surfacevascular stent

Identifiers

PMID38062750
PMCPMC10731649
OpenAlexW4389486506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.